Document is current
Any future updates will be listed below
-
Authors
Deshors, Pauline https://orcid.org/0000-0003-2276-2316
Kheil, Ziad
Ligat, Laetitia
Gouazé-Andersson, Valerie https://orcid.org/0000-0002-1797-515X
Cohen-Jonathan Moyal, Elizabeth
- License Information
-
More Information
Article History
Received: 3 June 2024
Revised: 12 May 2025
Accepted: 22 May 2025
First Online: 4 June 2025
Competing interests
: EC-JM. has received a research grant from Novocure. Inhibiting FGFR in association with Tumour Treating Fields has been patented with EC-JM and VG-A as patent inventors. EC-JM., PD and VG-A have received travelling grants and speakers’ honoraria from Novocure. The conceptualization, design, data collection, analysis and interpretation were performed by the authors independently of Novocure. Manuscript was reviewed by Novocure.
: GSC were obtained as part of the STEMRI clinical trial (NCT01872221) with written informed consent from patients admitted to the Neurosurgery Department at Toulouse University Hospital, and they were processed in accordance with the establishment’s. Human Research Ethics Committee (ethical code: 12TETE01; ID-RCB number: 2012-A00585-38; date of approval: 7 May 2012). This study was performed in accordance with the Declaration of Helsinki.
